Merck Canada said it has successfully completed negotiations on its PAH therapy Winrevair with the pan‑Canadian Pharmaceutical Alliance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback